Preparedness for healthy ageing and polysubstance use in long-term cannabis users: a population-representative longitudinal study.
Journal
The lancet. Healthy longevity
ISSN: 2666-7568
Titre abrégé: Lancet Healthy Longev
Pays: England
ID NLM: 101773309
Informations de publication
Date de publication:
10 2022
10 2022
Historique:
received:
17
05
2022
revised:
12
08
2022
accepted:
18
08
2022
entrez:
6
10
2022
pubmed:
7
10
2022
medline:
12
10
2022
Statut:
ppublish
Résumé
Cannabis is often characterised as a young person's drug. However, people who began consuming cannabis in the 1970s and 1980s are no longer young and some have consumed it for many years. This study tested the preregistered hypothesis that long-term cannabis users show accelerated biological ageing in midlife and poorer health preparedness, financial preparedness, and social preparedness for old age. In this longitudinal study, participants comprised a population-representative cohort of 1037 individuals born in Dunedin, New Zealand, between April, 1972, and March, 1973, and followed to age 45 years. Cannabis, tobacco, and alcohol use and dependence were assessed at ages 18 years, 21 years, 26 years, 32 years, 38 years, and 45 years. Biological ageing and health, financial, and social preparedness for old age were assessed at age 45 years. Long-term cannabis users were compared using independent samples t tests with five groups: lifelong cannabis non-users, long-term tobacco users, long-term alcohol users, midlife recreational cannabis users, and cannabis quitters. In addition, regression analyses tested dose-response associations for continuously measured persistence of cannabis dependence from age 18 years to 45 years, with associations adjusted for sex, childhood socioeconomic status, childhood IQ, low childhood self-control, family substance dependence history, and persistence of alcohol, tobacco, and other illicit drug dependence. Of 997 cohort members still alive at age 45 years, 938 (94%) were assessed at age 45 years. Long-term cannabis users showed statistically significant accelerated biological ageing and were less equipped to manage a range of later-life health, financial, and social demands than non-users. Standardised mean differences between long-term cannabis users and non-users were large: 0·70 (95% CI 0·46 to 0·94; p<0·0001) for biological ageing, -0·72 (-0·96 to -0·49, p<0·0001) for health preparedness, -1·08 (-1·31 to -0·85; p<0·0001) for financial preparedness, and -0·59 (-0·84 to -0·34, p<0·0001) for social preparedness. Long-term cannabis users did not fare better than long-term tobacco or alcohol users. Tests of dose-response associations suggested that cannabis associations could not be explained by the socioeconomic origins, childhood IQ, childhood self-control, and family substance-dependence history of long-term cannabis users. Statistical adjustment for long-term tobacco, alcohol, and other illicit drug dependence suggested that long-term cannabis users' tendency toward polysubstance dependence accounted for their accelerated biological ageing and poor financial and health preparedness, although not for their poor social preparedness (β -0·10, 95% CI -0·18 to -0·02; p=0·017). Long-term cannabis users are underprepared for the demands of old age. Although long-term cannabis use appears detrimental, the greatest challenge to healthy ageing is not use of any specific substance, but rather the long-term polysubstance use that characterises many long-term cannabis users. Substance-use interventions should include practical strategies for improving health and building financial and social capital for healthy longevity. The National Institute on Aging and the UK Medical Research Council. The Dunedin Research Unit is supported by the New Zealand Health Research Council and the New Zealand Ministry of Business, Innovation and Employment.
Sections du résumé
BACKGROUND
Cannabis is often characterised as a young person's drug. However, people who began consuming cannabis in the 1970s and 1980s are no longer young and some have consumed it for many years. This study tested the preregistered hypothesis that long-term cannabis users show accelerated biological ageing in midlife and poorer health preparedness, financial preparedness, and social preparedness for old age.
METHODS
In this longitudinal study, participants comprised a population-representative cohort of 1037 individuals born in Dunedin, New Zealand, between April, 1972, and March, 1973, and followed to age 45 years. Cannabis, tobacco, and alcohol use and dependence were assessed at ages 18 years, 21 years, 26 years, 32 years, 38 years, and 45 years. Biological ageing and health, financial, and social preparedness for old age were assessed at age 45 years. Long-term cannabis users were compared using independent samples t tests with five groups: lifelong cannabis non-users, long-term tobacco users, long-term alcohol users, midlife recreational cannabis users, and cannabis quitters. In addition, regression analyses tested dose-response associations for continuously measured persistence of cannabis dependence from age 18 years to 45 years, with associations adjusted for sex, childhood socioeconomic status, childhood IQ, low childhood self-control, family substance dependence history, and persistence of alcohol, tobacco, and other illicit drug dependence.
FINDINGS
Of 997 cohort members still alive at age 45 years, 938 (94%) were assessed at age 45 years. Long-term cannabis users showed statistically significant accelerated biological ageing and were less equipped to manage a range of later-life health, financial, and social demands than non-users. Standardised mean differences between long-term cannabis users and non-users were large: 0·70 (95% CI 0·46 to 0·94; p<0·0001) for biological ageing, -0·72 (-0·96 to -0·49, p<0·0001) for health preparedness, -1·08 (-1·31 to -0·85; p<0·0001) for financial preparedness, and -0·59 (-0·84 to -0·34, p<0·0001) for social preparedness. Long-term cannabis users did not fare better than long-term tobacco or alcohol users. Tests of dose-response associations suggested that cannabis associations could not be explained by the socioeconomic origins, childhood IQ, childhood self-control, and family substance-dependence history of long-term cannabis users. Statistical adjustment for long-term tobacco, alcohol, and other illicit drug dependence suggested that long-term cannabis users' tendency toward polysubstance dependence accounted for their accelerated biological ageing and poor financial and health preparedness, although not for their poor social preparedness (β -0·10, 95% CI -0·18 to -0·02; p=0·017).
INTERPRETATION
Long-term cannabis users are underprepared for the demands of old age. Although long-term cannabis use appears detrimental, the greatest challenge to healthy ageing is not use of any specific substance, but rather the long-term polysubstance use that characterises many long-term cannabis users. Substance-use interventions should include practical strategies for improving health and building financial and social capital for healthy longevity.
FUNDING
The National Institute on Aging and the UK Medical Research Council. The Dunedin Research Unit is supported by the New Zealand Health Research Council and the New Zealand Ministry of Business, Innovation and Employment.
Identifiants
pubmed: 36202130
pii: S2666-7568(22)00201-X
doi: 10.1016/S2666-7568(22)00201-X
pmc: PMC9552770
mid: NIHMS1840503
pii:
doi:
Substances chimiques
Hallucinogens
0
Illicit Drugs
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e703-e714Subventions
Organisme : NIA NIH HHS
ID : R01 AG049789
Pays : United States
Organisme : Medical Research Council
ID : MR/P005918/1
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : R01 AG073207
Pays : United States
Organisme : Medical Research Council
ID : MR/P005918
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : R01 AG032282
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG069939
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests We declare no competing interests.
Références
JAMA Pediatr. 2021 Apr 1;175(4):377-384
pubmed: 33464286
Soc Psychiatry Psychiatr Epidemiol. 2015 May;50(5):679-93
pubmed: 25835958
Eur Arch Psychiatry Clin Neurosci. 2019 Feb;269(1):5-15
pubmed: 30671616
Int J Behav Dev. 2015 Jan 1;39(1):20-31
pubmed: 25580043
Am J Public Health. 2002 Jun;92(6):990-6
pubmed: 12036794
J Am Geriatr Soc. 2015 Dec;63(12):2519-2525
pubmed: 26566992
Addiction. 2017 Mar;112(3):516-525
pubmed: 27767235
Drug Alcohol Depend. 2020 Jul 1;212:107993
pubmed: 32360455
Curr Opin Psychol. 2021 Apr;38:19-24
pubmed: 32736227
Brain Sci. 2019 Jul 16;9(7):
pubmed: 31315249
Prog Neuropsychopharmacol Biol Psychiatry. 2013 Oct 1;46:25-8
pubmed: 23820464
Drug Alcohol Depend. 2016 Dec 01;169:56-63
pubmed: 27776245
Addict Behav. 2020 Oct;109:106479
pubmed: 32485547
Addiction. 2015 Jan;110(1):19-35
pubmed: 25287883
Biol Psychiatry Cogn Neurosci Neuroimaging. 2021 Jun;6(6):603-606
pubmed: 33508497
Health Educ Behav. 2019 Aug;46(4):656-665
pubmed: 30786755
Clin Psychol Sci. 2016 Nov;4(6):1028-1046
pubmed: 28008372
JAMA. 2019 Feb 12;321(6):602-603
pubmed: 30676631
Am J Drug Alcohol Abuse. 2017 Sep;43(5):567-575
pubmed: 27929672
Am J Psychiatry. 2022 May;179(5):362-374
pubmed: 35255711
Gerontology. 2022;68(1):17-29
pubmed: 33946077
Drug Alcohol Depend. 2022 Apr 1;233:109363
pubmed: 35231715
Nat Hum Behav. 2020 Mar;4(3):255-264
pubmed: 31959926
Proc Natl Acad Sci U S A. 2021 Jan 19;118(3):
pubmed: 33397808
Lancet. 1992 May 23;339(8804):1268-78
pubmed: 1349675
BMJ Open. 2016 Nov 7;6(11):e011891
pubmed: 27821595
Psychol Med. 2010 Jun;40(6):899-909
pubmed: 19719899
Am J Epidemiol. 2011 Jan 15;173(2):192-200
pubmed: 21059808
Perspect Psychol Sci. 2015 Mar;10(2):227-37
pubmed: 25910392
Neuropsychologia. 2009 Aug;47(10):2015-28
pubmed: 19467352
Subst Use Misuse. 2018 Oct 15;53(12):1937-1950
pubmed: 29509060
Sci Rep. 2019 Jan 15;9(1):142
pubmed: 30644411